viloxazine has been researched along with Central Nervous System Diseases in 1 studies
Viloxazine: A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Viloxazine has a long history of clinical use in Europe as an antidepressant, and has recently been repurposed into an extended-release form for the treatment of attention-deficit/hyperactivity disorder in the USA." | 2.72 | Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status. ( Candler, SA; Findling, RL; Garcia-Olivares, J; Nasser, AF; Newcorn, JH; O'Neal, W; Schwabe, S; Yu, C, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Findling, RL | 1 |
| Candler, SA | 1 |
| Nasser, AF | 1 |
| Schwabe, S | 1 |
| Yu, C | 1 |
| Garcia-Olivares, J | 1 |
| O'Neal, W | 1 |
| Newcorn, JH | 1 |
1 review available for viloxazine and Central Nervous System Diseases
| Article | Year |
|---|---|
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status.
Topics: Administration, Oral; Adrenergic Uptake Inhibitors; Animals; Attention Deficit Disorder with Hyperac | 2021 |